Table 4. Efficacy of blockers: summary of post hoc analyses* from bitter rankings in the paired-comparison test 1 by TAS2R38 genotype for each of the two blockers when combined with PROP in each of the two groups: children and adults (means ± SEM).
Blocker = NaG | Genotype | PROP | PROP+NaG | NaG | Diluent |
Children | AA | 2.7±0.2a | 2.4±0.2a | 2.8±0.2a | 2.1±0.2a |
AP | 3.5±0.1a | 3.1±0.1a | 1.9±0.1b | 1.6±0.1b | |
PP | 3.5±0.1a | 3.2±0.1a | 1.6±0.1b | 1.7±0.1b | |
All genotypes | 3.3±0.1a | 2.9±0.1a | 2.1±0.1b | 1.7±0.1b | |
Adults | AA | 2.5±0.2a,b | 3.0±0.1a | 2.5±0.2a,b | 1.9±0.2b |
AP | 3.5±0.1a | 3.3±0.1a | 1.8±0.1b | 1.4±0.1b | |
PP | 3.5±0.1a | 3.4±0.1a | 1.9±0.1b | 1.2±0.1b | |
All genotypes | 3.3±0.1a | 3.2±0.1a | 2.0±0.1b | 1.5±0.1c | |
Blocker = MSG | Genotype | PROP | PROP+MSG | MSG | Diluent |
Children | AA | 2.4±0.2a | 2.8±0.2a | 2.8±0.2a | 2.0±0.2a |
AP | 3.3±0.1a | 3.0±0.1a | 2.2±0.2b | 1.5±0.1c | |
PP | 3.2±0.2a | 3.1±0.2a | 1.8±0.2b | 1.9±0.2b | |
All genotypes | 3.0±0.1a | 3.0±0.1a | 2.3±0.1b | 1.7±0.1c | |
Adults | AA | 2.6±0.2a | 2.7±0.2a | 2.8±0.2a | 1.9±0.2a |
AP | 3.4±0.1a | 3.2±0.1a | 2.0±0.1b | 1.4±0.1c | |
PP | 3.5±0.1a | 3.3±0.1a | 2.0±0.1b | 1.2±0.1b | |
All genotypes | 3.2±0.1a | 3.1±0.1a | 2.2±0.1b | 1.5±0.1c |
Abbreviations: PROP, propylthiouracil; SEM, standard error of the mean. Putative bitter blockers—NaG, 0.3 M sodium gluconate; MSG, 0.1 M glutamate. Rankings for bitterness range from 1 (least) to 4 (most); see Table S1 for ranking procedure. Different letters indicate rankings that are statistically different from each other within each row. Genotypes (AA, AP, PP) refer to the bitter-sensitive (P) and bitter-insensitive (A) forms of A49P alleles of the TAS2R38 bitter receptor gene.1All Friedman statistical tests of rank tests were significant at p≤0.05.